Who
Thomas C. Chen
CEO
Company insider
Files Form 4 as: CEO, NeOnc Technologies Holdings.
In numbers
- Trades disclosed
- 32
- Buys
- 12
- Sells
- 2
- Bought
- $929K
- Sold
- $2.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Mar 2025
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K5,242 at $3.82 | filing |
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K5,242 at $3.82 | filing |
| 11 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K5,556 at $3.60 | filing |
| 11 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K5,556 at $3.60 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $70K12,757 at $5.49 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $70K12,757 at $5.49 | filing |
| 17 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $9,9982,472 at $4.04 | filing |
| 17 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $9,9872,472 at $4.04 | filing |
| 17 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $9,9982,472 at $4.04 | filing |
| 17 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $9,9872,472 at $4.04 | filing |
| 14 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $130K33,787 at $3.85 | filing |
| 14 Aug 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $130K33,787 at $3.85 | filing |
| 14 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $130K33,787 at $3.85 | filing |
| 14 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $130K33,787 at $3.85 | filing |
| 24 Apr 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $48K10,000 at $4.80 | filing |
| 24 Apr 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $48K10,000 at $4.80 | filing |
| 10 Apr 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $4,899948 at $5.17 | filing |
| 10 Apr 2026filed 20 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $4,901948 at $5.17 | filing |
| 22 May 2025filed 23 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K2,709 at $7.38 | filing |
| 21 May 2025filed 23 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $20K2,759 at $7.25 | filing |
News
NeOnc Technologies and the Department of Health - Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical CollaborationNTHI · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name Thomas C. Chen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.